实验性多参数磁共振成像对髂腔静脉血栓形成病理变化的特征描述
研究采用猪下腔静脉血栓模型,将13头猪按血栓慢性程度分为急性组(n=5)、亚急性组(n=4)和慢性组(n=4),平均血栓龄分别为6.4±2.5天、15.7±2.8天和28±5.7天,通过多参数MRI评估血栓信号。结果显示注射对比剂后T1弛豫时间和原生T2弛豫时间在三组间均有统计学显著差异。结论认为MRI特征可能有助于区分人类深静脉血栓的亚急性期和慢性期与急性期,但需进一步临床研究。
要点
- 猪下腔静脉血栓模型中,注射对比剂后T1弛豫时间在三组慢性程度间差异有统计学意义(P=0.026)。
- 急性组与慢性组注射对比剂后T1弛豫时间差异显著(P=0.003),亚急性组与急性组差异显著(P=0.027)。
- 原生T2弛豫时间在三组间差异有统计学意义(P=0.038),亚急性组与急性组、慢性组比较均差异显著。
核心结论
- 本研究在猪模型中显示MRI特征可能具有区分人类深静脉血栓亚急性期和慢性期与急性期的潜力。
- 作者认为需要进一步在人身上开展临床研究。
研究设计与样本
- 研究采用既往描述的猪下腔静脉血栓模型,在基线、血栓形成后即刻以及随访2至28天后进行MRI检查。
- 13头猪按疾病慢性程度分为急性组(n=5)、亚急性组(n=4)和慢性组(n=4),平均血栓龄分别为6.4±2.5天、15.7±2.8天和28±5.7天。
- 使用T1加权容积插值屏气检查序列将下腔静脉血栓勾画为感兴趣区,另用三种MRI序列评估血栓信号。
主要发现
- Kruskal-Wallis检验显示注射对比剂后T1弛豫时间在三组慢性程度间差异有统计学意义(P=0.026)。
- 急性组注射对比剂后T1弛豫时间为360.2±102.5 ms,与慢性组的336.7±55.2 ms差异显著(P=0.003);亚急性组为354.1±89.7 ms,与急性组差异显著(P=0.027)。
- 原生T2弛豫时间在三组间差异有统计学意义(P=0.038);急性组为160±86.7 ms,与亚急性组的142.3±55.4 ms差异显著(P=0.027);亚急性组与慢性组的178.4±11.7 ms差异显著(P=0.004)。
临床怎么用
- 作者提出一种无创且创新的方法,利用完全血管内体内猪模型实验性获得的下腔静脉中央深静脉血栓的MRI特征来表征不同慢性程度阈值。
- 作者认为无创确定这些特征对血管专科医生在选择纤溶治疗、经皮血栓切除或外科处理时可能至关重要。
局限性
- 作者结论指出需要进一步在人身上开展临床研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Iliocaval thrombotic obstruction is a challenging condition, especially because thrombus age and corresponding pathological remodeling at presentation are unknown, which directly impacts management. Our aim was to assess the ability of magnetic resonance imaging (MRI) in determining age thresholds of experimentally created inferior vena cava (IVC) thrombosis in pigs. METHODS: We used a previously described swine model of IVC thrombosis. The animals underwent MRI at baseline, immediately after thrombosis creation, and after a follow-up period extending from 2 to 28 days. Thirteen pigs were divided into three groups according to disease chronicity: acute group (AG; n = 5), subacute group (SAG; n = 4), and chronic group (CG; n = 4), with a mean thrombosis age of 6.4 ± 2.5 days, 15.7 ± 2.8 days, and 28 ± 5.7 days, respectively. A T1-weighted volumetric interpolated breath-hold examination sequence was used to anatomically delineate IVC thrombus as a region of interest. Three other MRI sequences were used to assess the thrombus signal. RESULTS: The Kruskal-Wallis test showed a statistically significant difference in T1 relaxation times after contrast injection (P = .026) between the three groups of chronicity. The AG (360.2 ± 102.5 ms) was significantly different from the CG (336.7 ± 55.2 ms; P = .003), and the SAG (354.1 ± 89.7 ms) was significantly different from the AG (P = .027). There was a statistically significant difference in native T2 relaxation times (P = .038) between the three groups. The AG (160 ± 86.7 ms) was significantly different from the SAG (142.3 ± 55.4 ms; P = .027), and the SAG was significantly different from the CG (178.4 ± 11.7 ms; P = .004). CONCLUSIONS: This study highlighted MRI characteristics in a swine model that might have the potential to significantly differentiate subacute and chronic stages from an acute stage of deep vein thrombosis in humans. Further clinical studies in humans are warranted. CLINICAL RELEVANCE: In addition to providing a better understanding of venous thrombosis remodeling over time, magnetic resonance imaging has the potential to be a tool that could allow us to characterize the composition of venous thrombus over an interval, allowing for a refined analysis of the local evolution of venous thrombosis. We propose a noninvasive and innovative method to characterize different thresholds of chronicity with magnetic resonance imaging features of central deep vein thrombosis of the inferior vena cava experimentally obtained using a totally endovascular in vivo swine model, mimicking human pathophysiology. Being able to determine these features noninvasively is critical for vascular specialists when it comes to choosing between fibrinolytic therapy, percutaneous thrombectomy, or surgical management.
引用
- Magnus L, Schwein A, Chinnadurai P, et al. Experimental multiparametric magnetic resonance imaging characterization of iliocaval venous thrombosis pathological changes. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38679142. doi:10.1016/j.jvsv.2024.101895
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。